ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko05164	Influenza A	14/100	167/7206	5.85728962489e-08
ko04621	NOD-like receptor signaling pathway	13/100	157/7206	2.09795097167e-07
ko04380	Osteoclast differentiation	12/100	134/7206	2.717958956e-07
ko05167	Kaposi's sarcoma-associated herpesvirus infection	14/100	191/7206	3.14092782266e-07
ko04668	TNF signaling pathway	10/100	120/7206	5.5150347238e-06
ko04217	Necroptosis	12/100	178/7206	5.63759359162e-06
ko05152	Tuberculosis	12/100	187/7206	9.36441554514e-06
ko05168	Herpes simplex infection	11/100	182/7206	3.95440851045e-05
ko04620	Toll-like receptor signaling pathway	8/100	100/7206	6.74788179906e-05
ko05162	Measles	8/100	120/7206	0.00024265668208
ko05160	Hepatitis C	9/100	153/7206	0.000253910336501
ko04060	Cytokine-cytokine receptor interaction	10/100	191/7206	0.000295085953944
ko05145	Toxoplasmosis	8/100	126/7206	0.000338765682035
ko04064	NF-kappa B signaling pathway	7/100	96/7206	0.000348664541063
ko05340	Primary immunodeficiency	4/100	30/7206	0.000725292684844
ko04210	Apoptosis	9/100	180/7206	0.000835307627946
ko05131	Shigellosis	6/100	82/7206	0.000918381447619
ko04666	Fc gamma R-mediated phagocytosis	7/100	122/7206	0.00146168018412
ko04660	T cell receptor signaling pathway	7/100	124/7206	0.00160605506103
ko04622	RIG-I-like receptor signaling pathway	5/100	62/7206	0.00161068123827
ko04672	Intestinal immune network for IgA production	4/100	37/7206	0.00162280174945
ko04062	Chemokine signaling pathway	9/100	201/7206	0.00181320703486
ko04630	Jak-STAT signaling pathway	7/100	132/7206	0.00229807965637
ko05132	Salmonella infection	6/100	98/7206	0.00231078405283
ko04623	Cytosolic DNA-sensing pathway	4/100	41/7206	0.00238512838856
ko05161	Hepatitis B	8/100	173/7206	0.00267134148497
ko04612	Antigen processing and presentation	5/100	77/7206	0.00417655600559
ko05133	Pertussis	5/100	87/7206	0.00700722553066
ko04662	B cell receptor signaling pathway	5/100	88/7206	0.00734925530255
ko05169	Epstein-Barr virus infection	8/100	206/7206	0.00763343533887
ko05120	Epithelial cell signaling in Helicobacter pylori infection	5/100	92/7206	0.00883432256338
ko05100	Bacterial invasion of epithelial cells	5/100	99/7206	0.0119119119598
ko05203	Viral carcinogenesis	9/100	277/7206	0.0143999615474
ko04142	Lysosome	6/100	151/7206	0.018200551362
ko04670	Leukocyte transendothelial migration	6/100	151/7206	0.018200551362
ko05166	HTLV-I infection	9/100	292/7206	0.0196605254281
ko05140	Leishmaniasis	4/100	75/7206	0.0200266595715
ko01524	Platinum drug resistance	4/100	76/7206	0.0209199160644
ko05130	Pathogenic Escherichia coli infection	4/100	77/7206	0.0218373604512
ko04215	Apoptosis - multiple species	3/100	47/7206	0.027064129448
ko04917	Prolactin signaling pathway	4/100	87/7206	0.0323708708052
ko05142	Chagas disease (American trypanosomiasis)	5/100	130/7206	0.0341608516382
ko04932	Non-alcoholic fatty liver disease (NAFLD)	6/100	182/7206	0.0404415242996
ko04931	Insulin resistance	5/100	137/7206	0.0413694231583
ko05321	Inflammatory bowel disease (IBD)	3/100	56/7206	0.0423417259663
ko05330	Allograft rejection	2/100	24/7206	0.0431660010429